Beside KP activation, studies reporting increased neopterin levels in obese (Brandacher et al., 2006; Oxenkrug et al., 2011; Mangge et al., 2014) also suggest the potential involvement of BH4 pathway in obesity-related depressive comorbidity, consistent with impairment of dopamine neurotransmission reported in obesity (Sharma and Fulton, 2013; Krishna et al., 2015). This evidence concerns the gene NPPA and obesity disorder.